IP-10 and CXCR3 contribute to the pathophysiological neuroinflammatory process in the development of Alzheimer’s disease by recruiting monocytes and activating astrocytes and glial cells [208]. This evidence concerns the gene CXCL10 and early-onset autosomal dominant Alzheimer disease.